161 related articles for article (PubMed ID: 10989677)
21. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
22. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
de Boer WA; Haeck PW; Otten MH; Mulder CJ
Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
[TBL] [Abstract][Full Text] [Related]
23. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
24. [Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
Kim N; Kim JJ; Choe YH; Kim HS; Kim JI; Chung IS; ;
Korean J Gastroenterol; 2009 Nov; 54(5):269-78. PubMed ID: 19934608
[TBL] [Abstract][Full Text] [Related]
25. Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Calvet X; Montserrat A; Güell M; Vergara M; Gené E
Eur J Gastroenterol Hepatol; 2004 Oct; 16(10):987-90. PubMed ID: 15371921
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori infection--current treatment practice.
Xia HH; Yu Wong BC; Talley NJ; Lam SK
Expert Opin Pharmacother; 2001 Feb; 2(2):253-66. PubMed ID: 11336584
[TBL] [Abstract][Full Text] [Related]
27. V Spanish Consensus Conference on Helicobacter pylori infection treatment.
Gisbert JP; Alcedo J; Amador J; Bujanda L; Calvet X; Castro-Fernández M; Fernández-Salazar L; Gené E; Lanas Á; Lucendo AJ; Molina-Infante J; Nyssen OP; Pérez-Aisa A; Puig I
Gastroenterol Hepatol; 2022 May; 45(5):392-417. PubMed ID: 34629204
[TBL] [Abstract][Full Text] [Related]
28. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
31. Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies.
Chan FK; Sung JJ; Suen R; Wu JC; Ling TK; Chung SC
Aliment Pharmacol Ther; 2000 Jan; 14(1):91-5. PubMed ID: 10632651
[TBL] [Abstract][Full Text] [Related]
32. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
33. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Gisbert JP; Gisbert JL; Marcos S; Grávalos RG; Carpio D; Pajares JM
Aliment Pharmacol Ther; 1999 Oct; 13(10):1311-6. PubMed ID: 10540045
[TBL] [Abstract][Full Text] [Related]
34. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
Janssen MJ; Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
Aliment Pharmacol Ther; 2001 May; 15(5):613-24. PubMed ID: 11328254
[TBL] [Abstract][Full Text] [Related]
35. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
Kolkman JJ; Tan TG; Oudkerk Pool M; Van Kleef WA; Geraedts AA; Timmerman RJ; Crobach LF; Nicolai JJ; Wolff AA; Van Der Laan J
Aliment Pharmacol Ther; 1997 Dec; 11(6):1123-9. PubMed ID: 9663840
[TBL] [Abstract][Full Text] [Related]
36. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Van der Wouden EJ; Thijs JC; Zwet AA; Kooy A; Kleibeuker JH
Aliment Pharmacol Ther; 1999 Mar; 13(3):297-302. PubMed ID: 10102961
[TBL] [Abstract][Full Text] [Related]
37. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
38. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
Veldhuyzen van Zanten S; Chiba N; Barkun A; Fallone C; Farley A; Cockeram A; Dallaire C; Simms L; Nicholls B
Can J Gastroenterol; 2003 Sep; 17(9):533-8. PubMed ID: 14532926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
